Clinical trial

The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1

NCT01451333

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-09-01

PhasePHASE3

Study timeline

Study start (unknown)2011-09-01Date precision: month

Registry last updated2013-05-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionunresolved

Interventions

EfavirenzDRUG · verified · RxNorm: efavirenz

Sponsors & collaborators

Kirby Institutelead sponsor

Imperial College Londoncollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01451333 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.